T2 Biosystems to Report Second Quarter 2024 Financial Results and Business Updates on July 29, 2024
T2 Biosystems to Report Second Quarter 2024 Financial Results and Business Updates on July 29, 2024
LEXINGTON, Mass., July 22, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it will report financial results for the second quarter 2024 and business updates after market close on Monday, July 29, 2024.
馬薩諸塞州列剋星敦市，2024年7月22日，環球新聞線（GLOBE NEWSWIRE）──細菌檢測與抗生素耐藥基因快速檢測領域的領導者 T2 Biosystems, Inc.（NASDAQ：納斯達克股票代碼TTOO）今日宣佈，將在2024年7月29日週一的美國股市收盤後發佈2024年第二季度業績和業務更新。
Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at , on the Investors page in the Events & Presentations section. To listen to the conference call, please dial 1-888-506-0062 (US/Canada) or 1-973-528-0011 (International), passcode 109834, approximately ten to five minutes prior to the start time.
公司管理層將於東部時間下午4:30開始召開相應電話會議。有興趣聽取電話會議的投資者可以通過在投資者頁面的“事件和演示”部分的現場和存檔網絡直播來獲取會議信息。如需收聽電話會議，請於開始時間前五到十分鐘撥打1-888-506-0062（美國和加拿大）或1-973-528-0011（國際），通行證號碼爲109834。
About T2 Biosystems
T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. T2 Biosystems' products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance (T2MR) technology. T2 Biosystems has an active pipeline of future products, including the U.S. T2Resistance Panel, the Candida auris test, and the T2Lyme Panel. For more information, please visit .
t2 biosystems簡介
t2 biosystems是治療敗血症病原體和抗生素耐藥基因快速檢測技術領導者，致力於通過幫助臨床醫生更快地有效地治療患者，提高患者護理質量和降低護理成本。t2 biosystems的產品包括t2dx儀器、t2細菌檢測板、t2念珠菌檢測板、t2耐藥性檢測板和t2生物威脅檢測板，採用獨家的t2核磁共振（t2mr）技術推動。t2 biosystems有一個積極的未來產品管線，包括美國t2耐藥性檢測板、白念珠菌測試和t2萊姆病檢測板。欲了解更多信息，請訪問。
Investor Contact:
Philip Trip Taylor, Gilmartin Group
ir@T2Biosystems.com
415-937-5406
投資者聯繫人：
Philip Trip Taylor，Gilmartin Group
ir@T2Biosystems.com
415-937-5406
Source: T2 Biosystems, Inc.
來源：T2 Biosystems, Inc。